Shan Ahmed Khan, Author at TechStock²

Chick-fil-A Set to Return to Portland in Early 2026 at Former Strip Club Near Mall 205, as Christmas Eve Dining Hours Go Top of Mind

PORTLAND, Ore. — December 24, 2025. On a day when millions of Americans are asking the same practical question — “What’s open on Christmas Eve and Christmas Day?” — Portland is also buzzing about a very different kind of food-and-hours headline: Chick-fil-A is preparing to return to Portland proper for the first time in roughly two decades, with an early 2026 opening now being touted for a high-profile site in Southeast Portland. KGW The new restaurant is slated for the former Venue Gentleman’s Club property on Southeast Stark Street, just north of Mall 205 — a location that has already

24 December 2025

Stock Market

Dollarama Stock (TSX: DOL) Near Fresh Highs on Dec. 24, 2025: Earnings Momentum, Global Expansion, and a Valuation Test

Dollarama is ending 2025 in the spotlight as investors weigh a familiar question with an unusually sharp edge: how much is too much to pay for a business that keeps delivering? On December 24, 2025, the discussion is unfolding against a holiday-thinned trading session in Canada—markets are scheduled to close early—after the S&P/TSX set new records and heads toward its best annual performance since 2009. Reuters At the stock level, Dollarama has been pressing toward the upper end of its recent range, closing around C$204.69 in the latest session cited by multiple market trackers—right where the latest valuation commentary is

24 December 2025

Earnings Reports·Financial Analysis·Investing·Retail Industry·Stock Market·TSX:DOL

Reviva Pharmaceuticals (RVPH) Stock Plunges After FDA Calls for Second Phase 3 Trial: News, Forecasts, and Analyst Takeaways on Dec. 24, 2025

Reviva Pharmaceuticals Holdings, Inc. (NASDAQ: RVPH) is in the spotlight on December 24, 2025 after a sharp selloff driven by a major regulatory development: the U.S. Food and Drug Administration recommended that Reviva run an additional Phase 3 trial for its lead schizophrenia candidate, brilaroxazine, before filing a New Drug Application (NDA). SEC+1 Shares were trading around $0.32 after the drop, reflecting how quickly biotech valuations can reprice when timelines and funding needs change—especially for micro-cap clinical-stage companies. StockAnalysis What happened to Reviva Pharmaceuticals stock on December 24, 2025? The core catalyst is a regulatory “reset” of the near-term approval

24 December 2025

FDA News·Financial Forecasts·Investment Analysis·NASDAQ:RVPH·Pharmaceuticals·Stock Market

Regencell Bioscience Holdings Limited (RGC) Stock: News, Forecasts, and Fresh Analysis for Dec. 24, 2025

Dec. 24, 2025 — Regencell Bioscience Holdings Limited (NASDAQ: RGC) is having one of those “stock market is a strange animal” moments again: the share price is moving sharply on a story dominated less by traditional fundamentals and more by market structure—low float, extreme volatility, and ongoing legal overhang. As of Dec. 24, 2025, RGC was trading around $25.25, up roughly 14% on the day. Below is a complete, publication-ready roundup of what’s new today (12/24/2025), what the most current forecasts/models are implying, and what the latest filings and third‑party analysis say about the risks that keep following this stock

24 December 2025

Biotechnology·Financial News·Investment Analysis·Market Forecasts·NASDAQ:RGC·Stock Market

Stock Market Today: U.S. Futures Dip on Christmas Eve as S&P 500 Holds Record High and GDP Surprise Trims Rate‑Cut Bets

Wall Street is heading into Christmas Eve trading (Wednesday, December 24, 2025) with a familiar holiday mix: thin liquidity, an early close, and outsized market attention on macro headlines after the S&P 500 finished Tuesday at a fresh record. U.S. stock index futures were modestly lower in premarket action, as traders weighed an unexpectedly strong U.S. growth reading against stubborn inflation signals that are complicating the path for Federal Reserve rate cuts in 2026. Reuters+2Reuters+2 This year’s story has also been shaped by a unique wrinkle: several key government economic releases were delayed by a federal shutdown, meaning investors have

24 December 2025

Financial Analysis·Investments·Market News·Stock Market·U.S. Economy

Canopy Growth (CGC) Stock on Dec. 24, 2025: Schedule III Executive Order, MTL Cannabis Deal, and the Latest Forecasts

Canopy Growth Corporation (NASDAQ: CGC, TSX: WEED) is ending 2025 with something cannabis stocks haven’t seen in a while: sustained, headline-driven volatility — the kind that can lift prices fast, then yank them back down just as quickly. As of Dec. 24, 2025, CGC was trading around $1.40 in U.S. markets, after closing at $1.40 on Dec. 23 and showing a modest uptick in early premarket indications. StockAnalysis That price tag doesn’t tell the story by itself. December’s story is about policy momentum in Washington, a fresh Canadian acquisition announcement, and a market that’s still trying to decide whether Canopy

24 December 2025

Business News·Cannabis Industry·Financial Forecasts·Investment Analysis·NASDAQ:CGC·Stock Market·TSX:WEED

Indaptus Therapeutics (INDP) Stock in Focus on Dec. 24, 2025: $6M Financing, Leadership Reset, and the Dilution Question

Indaptus Therapeutics, Inc. (NASDAQ: INDP) is getting unusual attention heading into December 24, 2025, after a late-December SEC filing laid out a $6.0 million preferred-stock financing, a boardroom reshuffle, and a new co-CEO / chairman appointment—a mix that can ignite short-term trading interest while also forcing investors to re-run the long-term share-count math. SEC+1 The key tension is straightforward: the deal injects capital into a clinical-stage biotech that has been funding itself through repeated capital raises, but it also introduces a preferred security that—if shareholders approve conversion—could translate into up to 111 million common shares. In micro-cap land, that number

24 December 2025

Biotechnology·Company News·Financial Analysis·Investment Strategies·NASDAQ:INDP·Stock Market

NVIDIA Stock News Today (Dec 24, 2025): NVDA Eyes China H200 Shipments as Wall Street Lifts 2026 Forecasts

NVIDIA Corporation (NASDAQ: NVDA) is heading into Christmas Eve with a familiar mix of fuel and friction: a powerful AI demand narrative, a fresh policy twist on China chip exports, and the kind of valuation debate that never sleeps—even when the market calendar tries to. NVDA last traded around $189.21 (up about 3% from the prior close), keeping the stock near the center of the “Magnificent Seven” conversation as investors position for 2026. StockAnalysis+1 The big story underpinning today’s NVIDIA stock chatter is geopolitical and commercial at the same time: Nvidia’s H200 AI chip is back in play for China,

24 December 2025

Investment·NASDAQ:NVDA·NVIDIA·Stock Market·Tech News·Wall Street

Churchill Capital Corp X (CCCX) Stock News on Dec. 24, 2025: Infleqtion Quantum SPAC Deal, Latest Catalysts, and What Comes Next

Churchill Capital Corp X (NASDAQ: CCCX) is back on traders’ radar heading into Dec. 24, 2025, after a sharp move higher this week that market watchers have largely tied to headline-driven momentum around its planned merger partner, Infleqtion—a neutral-atom quantum technology company. TipRanks+1 If you’ve followed the “Churchill” name since the SPAC boom, the setup will feel familiar: a listed blank-check vehicle, a buzzy frontier-tech target, a defined transaction valuation—and a stock price that can swing hard as sentiment shifts from “deal math” to “story stock.” Business Wire+1 Below is what’s driving CCCX stock right now, what the most credible

24 December 2025

Investment Insights·Market Analysis·NASDAQ:CCCX·NASDAQ:CCXI·NASDAQ:CCXIU·Stock Market

Tilray Brands (TLRY) Stock News Today: Cannabis Rescheduling, Earnings Date, Reverse Split, and Analyst Forecasts (Dec. 24, 2025)

Tilray Brands, Inc. (NASDAQ: TLRY) has spent December doing what cannabis stocks do best: moving fast, arguing loudly with gravity, and reacting to headlines like they’re caffeine. As of Wednesday, December 24, 2025, TLRY is trading around $10.53. The reason investors keep refreshing their screens is simple: U.S. federal cannabis policy may be shifting in a meaningful (but not instantly transformative) way. President Donald Trump signed an executive order on December 18, 2025 directing the process to reclassify marijuana from Schedule I to Schedule III, a move that could eventually reduce tax burdens and ease certain business constraints across the

24 December 2025

Business News·Cannabis Industry·Company Earnings·Investment Analysis·NASDAQ:TLRY·Stock Market

Sable Offshore Corp (SOC) Stock News Today: PHMSA Clears Las Flores Pipeline Restart — Latest Price, Forecasts, and What Comes Next (Dec. 24, 2025)

Sable Offshore Corp. (NYSE: SOC) is back in the spotlight on December 24, 2025, after a key federal regulatory decision reignited investor optimism about the company’s ability to restart a long-idled California pipeline system—an outcome that matters because Sable’s business is heavily concentrated in a single offshore project. The catalyst: the U.S. Department of Transportation’s Pipeline and Hazardous Materials Safety Administration (PHMSA) approved Sable’s Restart Plan for the Las Flores Pipeline System, specifically Lines CA-324 and CA-325—a milestone Sable disclosed in a recent SEC filing. SEC+1 The market reaction has been swift and volatile. SOC recently closed at $10.36 after

24 December 2025

Company News·Energy Sector·Investment Analysis·NYSE:SOC·Stock Market

Reddit (RDDT) Stock News Today (Dec. 24, 2025): Needham Names Reddit a 2026 Top Pick, Insider Form 4 Filed, and the Latest Analyst Forecasts

Reddit, Inc. (NYSE: RDDT) is back in the spotlight on December 24, 2025, after fresh Wall Street commentary and newly surfaced insider-trading disclosures helped reset the conversation around what’s next for the social platform’s stock heading into 2026. As of the latest available quote on Dec. 24, RDDT was indicated around $225.82, down about 3.17% versus the previous close, with a market capitalization near $43.0 billion. What’s driving the renewed attention isn’t a single headline product launch or earnings release. Instead, it’s a combination of bullish analyst conviction—most notably Needham’s “Top Pick for 2026” call—and a Form 4 filing showing

24 December 2025

Analyst Ratings·Insider Trading·NYSE:RDDT·Stock Market News

Previous 1 … 547 548 549 550 551 … 883 Next

Rio Tinto stock jumps as Glencore mega-merger is shelved; what to watch next week

7 February 2026

Rio Tinto’s U.S. shares closed up 2.5% at $93.37 Friday after the company ruled out a merger with Glencore, triggering a six-month “no-bid” lockout under UK takeover rules. Both companies cited disagreements over valuation. Attention now turns to Rio’s Feb. 19 results and iron ore prices, which fell below $100 a tonne amid weak Chinese demand.

iFAST share price drops 3% as markets shut; earnings next week in focus

7 February 2026

iFAST shares fell 3.2% to S$9.64 in heavy trading Friday, closing near the day’s low as investors awaited FY2025 results due Feb. 12. The stock is about 13% below its 52-week high. iFAST recently agreed to buy a 30% stake in Financial Alliance for S$19.6 million, pending regulatory approval. Assets under administration stood at S$30.62 billion as of Sept. 30.

Sembcorp Industries share price: what to watch after Friday dip as Feb 25 results near

7 February 2026

Sembcorp shares closed at S$6.05 on Friday, down 0.33%, as Singapore’s STI dropped 0.8%. Shareholders approved the A$6.5 billion Alinta Energy takeover on Jan 30, but the deal still faces regulatory and closing conditions. Sembcorp will release FY2025 results on Feb 25 before market open. Trading volume reached about 4.3 million shares.

Seatrium stock slips to S$2.06 — what to watch after an AmFELS date fix and ahead of results

7 February 2026

Seatrium shares closed at S$2.06 on Friday, down nearly 1%. The company corrected the completion date of its AmFELS yard divestment to Jan. 30, 2026, in a filing this week. Investors remain focused on offshore wind contracts and ongoing arbitration tied to the DolWin 5 project. About 15.4 million shares changed hands during the session.